Huixi Li Selected Research

guanosine 5'-phosphoimidazolide

4/2015

Novel therapeutic approach for neurogenic erectile dysfunction: effect of neurotrophic tyrosine kinase receptor type 1 monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huixi Li Research Topics

Disease

9	Erectile Dysfunction 01/2021 - 12/2013
3	Stress Urinary Incontinence 01/2022 - 02/2017
3	Diabetes Mellitus 12/2015 - 07/2014
2	Ganglion Cysts (Ganglion) 01/2021 - 04/2015
2	Shock 01/2019 - 01/2016
1	Premature Ejaculation 02/2020
1	Azoospermia 09/2019
1	Inflammation (Inflammations) 01/2019
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2019
1	Pain (Aches) 01/2019
1	Obesity 02/2017
1	Hemorrhage 04/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Atrophy 03/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	Male Infertility (Male Sterility) 07/2014
1	Hyperglycemia 07/2014

Drug/Important Bio-Agent (IBA)

4	Therapeutic UsesIBA 01/2019 - 01/2015
3	Streptozocin (Streptozotocin)FDA Link 12/2015 - 07/2014
2	salicylhydroxamic acid (SHAM)IBA 08/2019 - 04/2015
2	baohuoside IIBA 03/2015 - 01/2015
1	Glial Cell Line-Derived Neurotrophic Factor ReceptorsIBA 01/2021
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021
1	dapoxetineIBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 09/2019
1	Nerve Growth Factor (NGF)IBA 01/2019
1	UroplakinsIBA 01/2019
1	FatsIBA 02/2017
1	Hemostatics (Antihemorrhagics)IBA 04/2016
1	Blood Glucose (Blood Sugar)IBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	Immunoglobulin G (IgG)IBA 04/2015
1	Phosphates (Orthophosphate)IBA 04/2015
1	trkA ReceptorIBA 04/2015
1	Monoclonal AntibodiesIBA 04/2015
1	guanosine 5'-phosphoimidazolideIBA 04/2015
1	CollagenIBA 03/2015
1	Advanced Glycation End ProductsIBA 06/2014
1	Phosphodiesterase 5 InhibitorsIBA 12/2013

Therapy/Procedure

2	Extracorporeal Shockwave Therapy 01/2016 - 12/2013
1	Intravenous Injections 01/2022
1	Therapeutics 01/2016